The OPALE Carnot institute is the reference partner to the healthcare industry for the research and development of innovative solutions aimed at diagnosis, treatment and follow-up of patients in the field of leukemia and related diseases, the deadliest blood cancer and first child cancer.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 1, Avenue Claude Vellefaux, Irsl - Hôpital Saint-Louis,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.opale.org
- Keywords
- Medicine, Hematology, Leukemia, Partnership, Research.
- HQ
- Paris, Île-de-France
- Competitors
- adreogen, Carnot MERS Institute, Institut Carnot ARTS, Institut Carnot I2C, Le Réseau des Carnot, NewClin, Institut Carnot CALYM, Consortium national de recherche sur les thérapies cellulaires et géniques (UNITC), OncoSTART, Institut de la Leucémie - Leukemia Institute Paris Saint-Louis.
Opale Carnot Institute Questions
Opale Carnot Institute's website is http://www.opale.org
Opale Carnot Institute's LinkedIn profile is https://fr.linkedin.com/company/institut-carnot-opale
Opale Carnot Institute has
7 employees.
View email and phone details for 7
employees at Opale Carnot Institute.
Opale Carnot Institute's industry is
Research Services
Opale Carnot Institute's top competitors are
Adreogen,
Carnot Mers Institute,
Institut Carnot Arts,
Institut Carnot I2c,
Le Réseau Des Carnot,
Newclin,
Institut Carnot Calym,
Consortium National De Recherche Sur Les Thérapies Cellulaires Et Géniques (Unitc),
Oncostart,
Institut De La Leucémie - Leukemia Institute Paris Saint-Louis.
Opale Carnot Institute's categories are Research Services
Opale Carnot Institute's founding year is 2020
